Biotechnology Market Trends 2022 | Segmentation, Outlook, Industry Report to 2030

The Global Biotechnology Market size is estimated to be USD 482.40 billion in 2019 and is predicted to reach USD 1257.41 billion by 2030 with a CAGR of 9.1% from 2020-2030.

Biotechnology utilizes biological systems, living organisms or their derivatives to develop or modify products or processes for specific use. Biotechnology couples cellular and biomolecular processes to develop technologies and products that help improve human lives. Biotechnology tools are useful in research supporting biodiversity and biosecurity throughout the world.

With the development of genetic engineering in 1970’s, research in biotechnology developed rapidly, as this filed of science offers new possibilities to make changes in the genetic material such as DNA of organisms. The field of biotechnology is progressing in rapidly and bringing amazing advances in fields ranging from medicine to neuroscience to computing. Some of the future advances involve development of bionic limbs, optogenetics, and molecular computers that are expected to bring humanity closer to the technical singularity. Increasing success in advancements combining biology with technology, opens new avenues in the biotechnology market.

Access Full Description of this report at:-

https://www.nextmsc.com/report/biotechnology-market

Top Companies: AstraZeneca, Pfizer, Celgene Corporation, Biogen, Abbott, Merck, Sanofi, Novo Nordisk, Novartis AG, and F. Hoffmann-La Roche Ltd and others.

Market Dynamics and Trends:

Growing population across the globe is one of the major factors that is driving the growth of biotechnology market. According to the UN, global population is expected to reach 9.7 billion in 2050 and further increase to 11.2 billion by 2100. This increasing population drives the demand for food and agricultural products and biotechnology can help ensure continued health and food security for this increasing global population. In addition this, there is rapid growth in the prevalence of chronic diseases such as hepatitis B, cancer, and other orphan disorders which fuels the demand for advanced therapeutic alternatives. Moreover, increasing government funding for research and development, decreasing prices of DNA sequencing and increased adoption of bioinformatics are some of the additional factors driving the growth of biotechnology market. However, risks associated with GM organisms and crops and ethical concerns associated with clinical trials are likely to hinder the market growth.

With the opportunities offered by this industry, large number of companies mainly focus on research and development and their primary growth strategy. Companies such as Roche, Pfizer, and Sanofi invest a significant amount of their revenue share into research and development. Moreover, these players also focus on expanding their existing business by collaborating and acquiring smaller players in the market. In 2017, the merger and acquisition deals in the life sciences arena summed up to $200 billion. Some of these acquisitions include Johnson & Johnson’s $30 billion acquisition of Actelion, and Gilead Science’s acquisition of Kite Pharma for $12 billion.

Request sample copy of this report at:-

https://www.nextmsc.com/Biotechnology-Market/request-sample

Market Segmentations and Scope of the Study:

The biotechnology market share is analysed on the basis of technology, application, and geography. The technology segment covers the market for DNA sequencing, nano-biotechnology, tissue engineering and regeneration, fermentation, cell based assay, PCR technology, chromatography, and others. On the basis of application the market is segmented into health, food & agriculture, natural resources & environment, industrial processing, bioinformatics, and others. Geographic breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and Rest of the World.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.